Hinge Health

Hinge Health CROIC

The Cash Return on Invested Capital (CROIC) of Hinge Health (HNGE) as of Oct 21, 2026 is 44.61 %. In the previous year, Cash Return on Invested Capital (CROIC) was 10.85 % — a change of 310.96% (higher).

CROIC

44.61 %

YoY

310.96%

Last updated:

Cash Return on Invested Capital (CROIC) of Hinge Health is 2025 44.61 % . Cash Return on Invested Capital (CROIC) of Hinge Health was 2024 10.85 % . It decreases by 310.96% higher compared to the previous year.

The Hinge Health CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2023
-16.04 USD
Jan 1, 2024
10.85 USD
Jan 1, 2025
44.61 USD
The Hinge Health CROIC history
YEARCROICYoY
44.61 %+310.96%
10.85 %-167.68%
-16.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hinge Health Stock analysis

What does Hinge Health do? Hinge Health, Inc. generates revenue through its TrueMotion platform, which provides AI-powered motion tracking for musculoskeletal care. The platform delivers personalized care programs covering prevention, acute injury treatment, chronic pain management, and post-surgical rehabilitation. Members access these services via the TrueMotion platform, which integrates with the Enso wearable device offering electrical nerve stimulation for pain relief. The company's AI-supported care team of licensed physical therapists, physicians, and health coaches monitors and adjusts care plans. Hinge Health's primary customers are employers and health plans that purchase the platform for their members, with the Enso device sold as an add-on to the platform subscription. The TrueMotion platform is designed for a spectrum of MSK care needs, from acute injury to chronic pain, and includes surgery decision support and post-surgical recovery programs. Enso, the electrical nerve stimulation wearable, is sold as a complementary product to enhance pain management within the platform's care continuum. The company's revenue model combines platform subscriptions with device sales, targeting employer and health plan segments that seek to reduce healthcare costs through proactive MSK management. Hinge Health's care team provides ongoing support through the AI-enhanced platform, ensuring continuous engagement and personalized care delivery. Hinge Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hinge Health stock

Cash Return on Invested Capital (CROIC) of Hinge Health is 44.61 % in 2025.

Cash Return on Invested Capital (CROIC) of Hinge Health changed from 10.85 % to 44.61 %, representing a 310.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Hinge Health since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Hinge Health with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hinge Health

All Key Metrics — Hinge Health